Niquitin Fruit (Nicotine Resinate)

Nicotine Resinate, the active ingredient in Niquitin Fruit, is a nicotinic receptor agonist presented as an oromucosal formulation for oromucosal use. It is employed to aid smoking cessation in adults who are trying to quit tobacco use.

GNH USA supplies Niquitin Fruit as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicotine Resinate is used in smoking cessation by targeting nicotinic receptors.

- Smoking cessation: helps reduce cravings and withdrawal symptoms in individuals attempting to quit tobacco. - Tobacco dependence: supports gradual reduction of nicotine intake during a quit attempt. - Nicotine addiction: assists in managing physiological dependence on nicotine.

Common Side Effects: - Mouth irritation: mild soreness or tingling at the site of administration. - Nausea: transient feeling of queasiness after use. - Hiccups: brief, involuntary diaphragmatic contractions. - Dizziness: light‑headed sensation, especially when standing quickly. - Headache: mild to moderate pain in the head region. - Altered taste: temporary metallic or bitter taste perception.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Cardiovascular events: chest pain, palpitations, or hypertension. - Seizures: rare occurrence of convulsive episodes. - Respiratory depression: unusually slow or shallow breathing. - Persistent vomiting: inability to retain fluids. - Unexplained fainting: sudden loss of consciousness.

Before initiating therapy, consider the following precautions: - Assess cardiovascular status: evaluate for recent myocardial infarction or uncontrolled hypertension. - Monitor for allergic reactions: watch for signs of rash, itching, or swelling. - Avoid concurrent nicotine products: do not combine with patches, gums, or inhalers. - Counsel on proper use: ensure patient understands oromucosal placement and dosing schedule. - Store at ambient temperature: keep in the original container, protect from moisture and direct heat.

Nicotine Resinate may interact with other medicines. Review the following:

Major Interactions (Avoid): - Monoamine oxidase inhibitors: increased risk of hypertensive crisis. - CYP2A6 inhibitors (e.g., methoxsalen): elevated nicotine plasma levels. - Other nicotine replacement therapies: risk of nicotine overdose.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Certain antidepressants (e.g., SSRIs): possible additive central nervous system effects. - Alcohol: may amplify nausea and dizziness.